The Quest for Immortality: Are we at the dawn of a biopharma golden age?
No industry is better poised to both capitalize on and drive the Quest for Immortality.
The sector’s promise and focus on innovation can attract new capital, but we expect growing pains too – increasing regulatory scrutiny, as well as budgetary challenges in making life-changing medicines available equitably to all.
“As companies continue to push the limit of innovation, we see bold ideas reaching the capital markets earlier, and expect biopharma to begin to tackle aging itself.”
Brian Abrahams
Biotechnology Analyst, RBC Capital Markets
Read more about how longer lifespans will impact healthcare.
The Individual Revolution: How will personalized medicine transform healthcare?
Personalized medicine is no longer confined to our dreams – it is here, and present in a wide range of healthcare services, from genomic sequencing of cancers tailoring treatment, to the promise of gene editing correcting a patient’s mutation within their own body.
We continue to see personalized therapeutics making waves and moving from rare diseases to more common indications. This will potentially expand the total addressable market, leaving fewer and fewer patients behind.
Find out more about how the Individual Revolution will impact healthcare.
AI Activated: Is AI the next frontier for robotic surgery?
As biopharma and tech continue to collaborate progressively closely, advances in AI will have great impact in the industry. Similarly to other industries, automation of repetitive tasks will make healthcare delivery more efficient and cost-effective.
In biopharma, AI provides the ability to develop better drugs at speed, while reducing cost. And AI also empowers robotic surgery, which is still in its infancy today.
Get deeper insights into how AI will impact healthcare.
Hybrid Living: Can healthcare bridge the virtual world and the real?
The COVID-19 pandemic certainly accelerated the growth of virtual healthcare and telemedicine. But we believe that these trends were present beforehand and will outlast the pandemic.
By offering more convenient service, faster scheduling, ease of access to specialists, reducing costs, and delivering care in the home, virtual healthcare can add value and improve outcomes. We expect continued growth and investment in the sector.
“Increasing engagement and simplifying logistics can benefit both patients and providers, and we believe the quality of virtual care, bolstered by new technologies and devices, is being underappreciated by the markets.”
Sean Dodge
Healthcare Technology Analyst, RBC Capital Markets
Discover how Hybrid Living will impact healthcare.
The Great Balancing Act: Can healthcare reimagine a more equitable future for all?
Healthcare has traditionally been considered a highly inelastic good – and placing a dollar value on a human life and wellbeing (either directly or indirectly through drug pricing) has been extremely controversial. This has underscored the need to find an appropriate balance of public vs. private interests.
Across the globe, countries will attempt to strike this balance in unique ways. U.S. dominance is being challenged by innovative companies from China, where R&D spending is rapidly accelerating.
Find out more about how the Great Balancing Act will impact healthcare.
